collection
MENU ▼
Read by QxMD icon Read
search

Pulmonary embolism: outpatient management strategy

shared collection
3 papers 0 to 25 followers
By Jason Mann No BS pulmonary critical care fellow
https://www.readbyqxmd.com/read/26231410/do-clinical-prediction-rules-for-acute-pulmonary-embolism-have-sufficient-sensitivity-to-identify-patients-at-very-low-risk-of-death
#1
COMMENT
Brit J Long, Alex Koyfman
No abstract text is available yet for this article.
February 2016: Annals of Emergency Medicine
https://www.readbyqxmd.com/read/26151264/six-months-vs-extended-oral-anticoagulation-after-a-first-episode-of-pulmonary-embolism-the-padis-pe-randomized-clinical-trial
#2
RANDOMIZED CONTROLLED TRIAL
Francis Couturaud, Olivier Sanchez, Gilles Pernod, Patrick Mismetti, Patrick Jego, Elisabeth Duhamel, Karine Provost, Claire Bal dit Sollier, Emilie Presles, Philippe Castellant, Florence Parent, Pierre-Yves Salaun, Luc Bressollette, Michel Nonent, Philippe Lorillon, Philippe Girard, Karine Lacut, Marie Guégan, Jean-Luc Bosson, Silvy Laporte, Christophe Leroyer, Hervé Décousus, Guy Meyer, Dominique Mottier
IMPORTANCE: The optimal duration of anticoagulation after a first episode of unprovoked pulmonary embolism is uncertain. OBJECTIVES: To determine the benefits and harms of an additional 18-month treatment with warfarin vs placebo, after an initial 6-month nonrandomized treatment period on a vitamin K antagonist. DESIGN, SETTING, AND PARTICIPANTS: Randomized, double-blind trial (treatment period, 18 months; median follow-up, 24 months); 371 adult patients who had experienced a first episode of symptomatic unprovoked pulmonary embolism (ie, with no major risk factor for thrombosis) and had been treated initially for 6 uninterrupted months with a vitamin K antagonist were randomized and followed up between July 2007 and September 2014 in 14 French centers...
July 7, 2015: JAMA: the Journal of the American Medical Association
https://www.readbyqxmd.com/read/26113241/immediate-discharge-and-home-treatment-with-rivaroxaban-of-low-risk-venous-thromboembolism-diagnosed-in-two-u-s-emergency-departments-a-one-year-preplanned-analysis
#3
MULTICENTER STUDY
Daren M Beam, Zachary P Kahler, Jeffrey A Kline
OBJECTIVES: The study hypothesis was that a target-specific anticoagulant would allow successful home treatment of selected patients with deep vein thrombosis (DVT) and pulmonary embolism (PE) diagnosed in two urban emergency departments (EDs). METHODS: A protocol was established for treating low-risk DVT or PE patients with rivaroxaban and clinic, follow-up at both 2 to 5 weeks, and 3 to 6 months. Patients were determined to be low-risk by using a modified version of the Hestia criteria, supplemented by additional criteria for patients with active cancer...
July 2015: Academic Emergency Medicine: Official Journal of the Society for Academic Emergency Medicine
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"